Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic

Benzinga01-07 01:18

Walgreens Boots Alliance Inc. (NASDAQ:WBA) will report its fiscal year 2025 first quarter results on Friday, January 10. Analysts expect the company to report adjusted earnings of 38 cents per share ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2501250177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-07 01:18","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2501250177","market":"us","top_or_hot":-1,"title":"Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic","media":"Benzinga","content":"<div>\n<p>Walgreens Boots Alliance Inc. (NASDAQ:WBA) will report its fiscal year 2025 first quarter results on Friday, January 10.\nAnalysts expect the company to report adjusted earnings of 38 cents per share ...</p>\n\n<a href=\"https://finance.yahoo.com/news/walgreens-faces-strategic-challenges-analysts-171834254.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWalgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-07 01:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/walgreens-faces-strategic-challenges-analysts-171834254.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Walgreens Boots Alliance Inc. (NASDAQ:WBA) will report its fiscal year 2025 first quarter results on Friday, January 10.\nAnalysts expect the company to report adjusted earnings of 38 cents per share ...</p>\n\n<a href=\"https://finance.yahoo.com/news/walgreens-faces-strategic-challenges-analysts-171834254.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BKVL7J92.USD","symbol_name":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","start_time":0,"source_url":"https://finance.yahoo.com/news/walgreens-faces-strategic-challenges-analysts-171834254.html","article_id":"2501250177","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501250177","pubTimestamp":1736183914,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Walgreens Boots Alliance Inc. will report its fiscal year 2025 first quarter results on Friday, January 10.Analysts expect the company to report adjusted earnings of 38 cents per share on revenue of $37.29 billion, according to estimates fromBenzinga Pro.JP Morgan analyst Lisa Gill writes that the focus will be on the retail pharmacy segment's performance and management comments on strategic initiatives.The analyst maintains an Outperform rating with a price target of $15.Recent stock volatility stemmed from a WSJ report last month that Walgreens Boots Alliance was in talks to be acquired by aprivate equity firm, Sycamore Partners.JP Morgan analysts write the chances of a leveraged buyout  for Walgreens Boots Alliance are low due to the complexity of involving multiple stakeholders, including the potential separation of Boots and the sale of VillageMD.While the idea of operating Walgreens as a private company has its merits, taking the company private is not JP Morgan's primary expecta","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","BK4585":"ETF&股票定投概念","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","BK4534":"瑞士信贷持仓","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","BK4588":"碎股","LBO":"WHITEWOLF PUBLICLY LISTED PRIVATE EQUITY ETF","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","BK4581":"高盛持仓","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4128":"药品零售","BK4504":"桥水持仓","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0106831901.USD":"贝莱德世界金融基金A2","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","BK4127":"投资银行业与经纪业","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","BK4516":"特朗普概念","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU0971096721.USD":"富达环球金融服务 A","LU1548497426.USD":"安联环球人工智能AT Acc","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","WBA":"沃尔格林联合博姿"},"translate_title":"沃尔格林面临战略挑战分析师谨慎乐观","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LBO":1,"WBA":0.9},"content_text":"Walgreens Boots Alliance Inc. (NASDAQ:WBA) will report its fiscal year 2025 first quarter results on Friday, January 10.\nAnalysts expect the company to report adjusted earnings of 38 cents per share on revenue of $37.29 billion, according to estimates from Benzinga Pro.\nJP Morgan analyst Lisa Gill writes that the focus will be on the retail pharmacy segment's performance and management comments on strategic initiatives.\nThe analyst maintains an Outperform rating with a price target of $15.\nRecent stock volatility stemmed from a WSJ report last month that Walgreens Boots Alliance was in talks to be acquired by a private equity firm, Sycamore Partners.\nJP Morgan analysts write the chances of a leveraged buyout (LBO) for Walgreens Boots Alliance are low due to the complexity of involving multiple stakeholders, including the potential separation of Boots and the sale of VillageMD.\nWhile the idea of operating Walgreens as a private company has its merits, taking the company private is not JP Morgan's primary expectation.\nReports suggest that such a deal would likely require divesting Boots and selling VillageMD, both of which have been on the market but haven't found buyers yet.\nAlthough Walgreens might now be more motivated to finalize these sales, past difficulties in securing buyers make it challenging to include both in an LBO.\nIf WBA were to go private without Boots or VillageMD, it could speed up planned store closures and cost-cutting measures.\nIn the fourth quarter of 2024, Walgreens announced a footprint optimization program that will target approximately 1,200 closures over the next three years.\nJP Morgan expects the first quarter of 2025 to mirror challenges seen in fiscal 2024, including impacts from sale-leasebacks, reduced equity income, and weaker profit margins due to a sluggish economy.\nAnalysts also highlight key retail trends, shifts in consumer behavior, progress in the Healthcare segment, and updates on the planned closure of around 500 stores in 2025 as important areas to watch.\nFor the long term, they emphasize the need for clarity on strategic plans for assets like VillageMD and Boots, as well as the company's approach to managing debt.\nPrice Action: WBA stock is up 2.16% at $9.71 at the last check on Monday.\nRead Next:\n\nSingapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor\n\nImage via Shutterstock\nLatest Ratings for WBA\n\n\n\nDate\nFirm\nAction\nFrom\nTo\n\n\n\n\nDec 2021\nUBS\nMaintains\n\nNeutral\n\n\nDec 2021\nMorgan Stanley\nDowngrades\nEqual-Weight\nUnderweight\n\n\nDec 2021\nMorgan Stanley\nDowngrades\nEqual-Weight\nUnderweight\n\n\n\n View More Analyst Ratings for WBA \n View the Latest Analyst Ratings \nUp Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.\nGet the latest stock analysis from Benzinga?\n\nThis article Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic originally appeared on Benzinga.com\n© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501250177"}